Transcatheter closure versus medical therapy of patent foramen ovale and cryptogenic stroke

Basil Vasilios D Thanopoulos1, Petros D Dardas, Evangelos Karanasios

  • 1Department of Cardiology, Aghia Sophia Children's Hospital, Athens, Greece. vthanop@otenet.gr

Insights

Device closure of patent foramen ovale (PFO) is a safe and effective alternative to antiplatelet therapy for preventing recurrent cryptogenic stroke (CS). PFO closure significantly reduced embolic events compared to antiplatelet therapy.

Area of Science:

  • Cardiology
  • Neurology
  • Medical Devices

Background:

  • No controlled data exist comparing device closure of patent foramen ovale (PFO) with medical treatment for cryptogenic stroke (CS).
  • Evaluating PFO closure efficacy and safety is crucial for managing CS patients.

Purpose of the Study:

  • To compare the efficacy and safety of PFO device closure versus antiplatelet therapy in patients with CS.
  • To assess the recurrence rate of stroke in patients with PFO and CS undergoing different treatments.

Main Methods:

  • A nonrandomized, prospective case series of 92 patients with PFO and CS.
  • Patients were treated with either antiplatelet agents (44) or PFO catheter closure using the Amplatzer PFO occluder (APFOO) (48).
  • A 2-year follow-up was completed for all patients.

Main Results:

  • PFO closure achieved 91% immediate complete closure, with no complications.
  • The PFO closure group had 0% incidence of embolic events/year, versus 14.75% in the antiplatelet therapy group (P < 0.001).
  • The antiplatelet group experienced 3 major and 6 minor hemorrhagic events.

Conclusions:

  • PFO closure with the APFOO is a viable alternative to medical treatment for CS.
  • Larger randomized trials are needed to confirm the superiority of this device over other occluders and medical therapies.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...